Masimo Corporation (MASI) - Net Assets

Latest as of December 2025: $721.20 Million USD

Based on the latest financial reports, Masimo Corporation (MASI) has net assets worth $721.20 Million USD as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($1.70 Billion) and total liabilities ($977.70 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Explore Masimo Corporation (MASI) cash flow conversion to assess how effectively this company generates cash.

Key Net Assets Metrics

Metric Value
Current Net Assets $721.20 Million
% of Total Assets 42.45%
Annual Growth Rate 15.51%
5-Year Change -53.48%
10-Year Change 28.73%
Growth Volatility 144.03

Masimo Corporation - Net Assets Trend (1998–2025)

This chart illustrates how Masimo Corporation's net assets have evolved over time, based on quarterly financial data. Explore Masimo Corporation (MASI) investment intensity to see how much of total assets are deployed in long-term investments.

Annual Net Assets for Masimo Corporation (1998–2025)

The table below shows the annual net assets of Masimo Corporation from 1998 to 2025. For live valuation and market cap data, see Masimo Corporation market capitalisation.

Year Net Assets Change
2025-12-31 $721.20 Million -31.44%
2024-12-31 $1.05 Billion -22.93%
2023-12-31 $1.36 Billion +1.93%
2022-12-31 $1.34 Billion -13.63%
2021-12-31 $1.55 Billion +10.13%
2020-12-31 $1.41 Billion +20.53%
2019-12-31 $1.17 Billion +20.52%
2018-12-31 $969.07 Million +33.84%
2017-12-31 $724.02 Million +29.24%
2016-12-31 $560.24 Million +103.20%
2015-12-31 $275.71 Million -10.41%
2014-12-31 $307.74 Million -5.72%
2013-12-31 $326.40 Million +18.40%
2012-12-31 $275.67 Million -1.43%
2011-12-31 $279.67 Million +21.57%
2010-12-31 $230.04 Million -20.59%
2009-12-31 $289.69 Million +31.98%
2008-12-31 $219.50 Million +46.27%
2007-12-31 $150.07 Million +163.45%
2006-12-31 $56.96 Million +156.35%
2005-12-31 $-101.08 Million +12.40%
2003-12-31 $-115.39 Million -15.17%
2002-12-31 $-100.19 Million -624.57%
1999-12-31 $19.10 Million +29.93%
1998-12-31 $14.70 Million --

Equity Component Analysis

This analysis shows how different components contribute to Masimo Corporation's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 137130000000.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2025)

Component Amount Percentage
Retained Earnings $1.34 Billion 185.72%
Common Stock $100.00K 0.01%
Other Comprehensive Income $-12.50 Million -1.73%
Total Equity $721.20 Million 100.00%

Masimo Corporation Competitors by Market Cap

The table below lists competitors of Masimo Corporation ranked by their market capitalization.

Company Market Cap
Skyworks Solutions Inc
NASDAQ:SWKS
 $9.34 Billion
Old Republic International Corp
NYSE:ORI
 $9.35 Billion
Globus Medical
NYSE:GMED
 $9.35 Billion
Puig Brands SA
MC:PUIG
 $9.36 Billion
Darling Ingredients Inc
NYSE:DAR
 $9.34 Billion
China Zheshang Bank Co Ltd
SHG:601916
 $9.33 Billion
Texas Pacific Land Trust
NYSE:TPL
 $9.33 Billion
Shandong Hualu Hengsheng Chemical Co Ltd
SHG:600426
 $9.32 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Masimo Corporation's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 1,051,900,000 to 721,200,000, a change of -330,700,000 (-31.4%).
  • Net loss of 151,500,000 reduced equity.
  • Share repurchases of 363,700,000 reduced equity.
  • New share issuances of 71,400,000 increased equity.
  • Other comprehensive income increased equity by 95,700,000.
  • Other factors increased equity by 17,400,000.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income $-151.50 Million -21.01%
Share Repurchases $363.70 Million -50.43%
Share Issuances $71.40 Million +9.9%
Other Comprehensive Income $95.70 Million +13.27%
Other Changes $17.40 Million +2.41%
Total Change $- -31.44%

Book Value vs Market Value Analysis

This analysis compares Masimo Corporation's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 13.44x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has decreased from 642.15x to 13.44x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
1998-12-31 $0.28 $178.78 x
1999-12-31 $0.36 $178.78 x
2002-12-31 $-3.04 $178.78 x
2003-12-31 $-3.50 $178.78 x
2005-12-31 $-7.71 $178.78 x
2006-12-31 $2.80 $178.78 x
2007-12-31 $2.51 $178.78 x
2008-12-31 $3.64 $178.78 x
2009-12-31 $4.80 $178.78 x
2010-12-31 $3.76 $178.78 x
2011-12-31 $4.55 $178.78 x
2012-12-31 $4.68 $178.78 x
2013-12-31 $5.68 $178.78 x
2014-12-31 $5.51 $178.78 x
2015-12-31 $5.13 $178.78 x
2016-12-31 $10.53 $178.78 x
2017-12-31 $12.96 $178.78 x
2018-12-31 $17.29 $178.78 x
2019-12-31 $20.45 $178.78 x
2020-12-31 $24.25 $178.78 x
2021-12-31 $26.87 $178.78 x
2022-12-31 $24.26 $178.78 x
2023-12-31 $25.23 $178.78 x
2024-12-31 $19.74 $178.78 x
2025-12-31 $13.31 $178.78 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Masimo Corporation utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -21.01%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -9.92%
  • • Asset Turnover: 0.90x
  • • Equity Multiplier: 2.36x
  • Recent ROE (-21.01%) is below the historical average (20.41%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
1998 -56.46% -488.24% 0.09x 1.22x $-9.77 Million
1999 -70.68% -201.49% 0.28x 1.27x $-15.41 Million
2002 0.00% -0.47% 1.19x 0.00x $9.84 Million
2003 0.00% -14.75% 1.16x 0.00x $4.65 Million
2005 0.00% 30.94% 1.07x 0.00x $43.49 Million
2006 319.21% 81.05% 1.41x 2.79x $176.13 Million
2007 28.16% 16.49% 1.09x 1.57x $27.25 Million
2008 14.55% 10.40% 1.05x 1.34x $9.99 Million
2009 18.44% 15.25% 0.98x 1.23x $24.36 Million
2010 32.30% 18.14% 1.31x 1.36x $50.77 Million
2011 23.01% 14.51% 1.20x 1.32x $36.02 Million
2012 22.80% 12.63% 1.32x 1.37x $34.96 Million
2013 17.88% 10.67% 1.25x 1.34x $25.73 Million
2014 23.70% 12.36% 1.04x 1.85x $41.92 Million
2015 30.25% 13.22% 1.05x 2.18x $55.76 Million
2016 53.67% 42.18% 0.87x 1.46x $244.64 Million
2017 18.18% 16.66% 0.87x 1.25x $59.21 Million
2018 19.97% 22.55% 0.74x 1.19x $96.64 Million
2019 16.80% 20.92% 0.67x 1.20x $79.43 Million
2020 17.07% 21.01% 0.67x 1.22x $99.54 Million
2021 14.81% 18.53% 0.66x 1.22x $74.58 Million
2022 10.72% 7.05% 0.63x 2.40x $9.61 Million
2023 5.97% 3.98% 0.67x 2.23x $-54.98 Million
2024 -28.99% -14.56% 0.80x 2.50x $-410.09 Million
2025 -21.01% -9.92% 0.90x 2.36x $-223.62 Million

Industry Comparison

This section compares Masimo Corporation's net assets metrics with peer companies in the Medical Devices industry.

Industry Context

  • Industry: Medical Devices
  • Average net assets among peers: $2,884,446,440
  • Average return on equity (ROE) among peers: -48.91%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Masimo Corporation (MASI) $721.20 Million -56.46% 1.36x $9.34 Billion
Abbott Laboratories (ABT) $26.81 Billion 22.24% 1.51x $148.99 Billion
Adagio Medical Holdings, Inc Common Stock (ADGM) $-132.02 Million 0.00% 0.00x $17.10 Million
Aethlon Medical Inc (AEMD) $5.12 Million -261.31% 0.44x $2.79 Million
Acutus Medical Inc (AFIB) $126.58 Million -80.56% 0.52x $903.35K
Adapthealth Corp (AHCO) $2.07 Billion 7.56% 1.54x $1.39 Billion
20/20 Biolabs, Inc. Common Stock (AIDX) $3.39 Million -59.65% 0.38x $10.04 Million
Allurion Technologies, Inc. (ALUR) $-77.98 Million 0.00% 0.00x $9.82 Million
Autonomix Medical, Inc. Common Stock (AMIX) $8.10 Million -140.88% 0.21x $3.99 Million
Artivion Inc (AORT) $24.90 Million 15.66% 0.41x $1.10 Billion
Apyx Medical Inc (APYX) $6.39 Million 7.83% 0.24x $153.68 Million

About Masimo Corporation

NASDAQ:MASI USA Medical Devices
Market Cap
$9.36 Billion
Market Cap Rank
#2388 Global
#861 in USA
Share Price
$178.78
Change (1 day)
+0.06%
52-Week Range
$127.40 - $178.81
All Time High
$303.29
Categories
Companies in USA Medical Devices
About

Masimo Corporation engages in the development, manufacture, and marketing of various patient monitoring technologies, and automation and connectivity solutions worldwide. It offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo Rainbow SET pla… Read more